| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |
| mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.22 |
2e-05 |
| mRNA |
Bexarotene |
FIMM |
pan-cancer |
AAC |
0.59 |
2e-05 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.21 |
2e-05 |
| mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
4e-05 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.22 |
4e-05 |
| mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
8e-05 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |